The R&D Tax Credit remains a vital incentive for reducing tax liability and incentivizing innovation across America. However, it also remains a source of scrutiny for the IRS and state taxing authorities.

Hosts Tim LeMasters⁠ with guest ⁠Tanner Niehaus, CPA⁠, discuss industry-specific R&D Tax Credit qualifications, IRS guidelines, and the importance of proper documentation.

Congress is advancing a sweeping tax bill that could restore full expensing for R&D under Section 174, reinstate 100% bonus depreciation, and make other long-awaited business tax changes—though its passage remains uncertain.

Hosts Dave McGuire and guest Jerry Hammel, CPA, discuss the first 100 days of the new administration and its impact on tax policy.

With the conclusion of the 2024 tax season near, now is the time to assess the evolving tax landscape and prepare for the year ahead.

President Trump’s 2025 tariff plan introduces auto, baseline, and reciprocal tariffs—with major economic impact. Discover key tax strategies to boost cash flow, reduce liabilities, and help businesses adapt to the evolving global trade environment.

On March 10, 2025, a bipartisan group reintroduced the American Innovation and R&D Competitiveness Act of 2025. This bill, sponsored by Republican Rep. Ron Estes of Kansas and Democrat Rep. Jon Larson of Connecticut, mirrors bills they introduced in 2019 and 2023.

Join us for the State of Specialty Tax Webinar Series, designed to equip CPAs and real estate professionals with the knowledge and strategies needed to navigate the complexities of tax year 2024 and beyond.

As the filing season for tax year 2024 begins, Section 174 remains a significant challenge for companies. While some taxpayers may claim they have no Section 174 costs, this position is difficult to defend for software and technology companies.

Government contractors play a key role in advancing research and development (R&D) across the aerospace, defense, technology, and healthcare industries. While the R&D Tax Credit is a valuable tax incentive for companies investing in research and development, contractors performing government-funded research face unique eligibility challenges.